CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment. [electronic resource]
- Journal of hematotherapy Apr 1998
- 151-7 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S.
1061-6128
10.1089/scd.1.1998.7.151 doi
Adult Antigens, CD34--immunology Bone Marrow Transplantation--adverse effects Cell Separation Female Humans Lymphocyte Depletion Male Middle Aged Morbidity Pilot Projects Survivors T-Lymphocytes--immunology Transplantation, Homologous